Angiographic findings and procedural outcome in the cohort based on preprocedural white count
| Quintile 1 (n=1480) | Quintile 2 (n=1391) | Quintile 3 (n=1463) | Quintile 4 (n=1413) | Quintile 5 (n=1432) | |
|---|---|---|---|---|---|
| *Complete data not available for all patients. | |||||
| ACC, American College of Cardiology; AHA, American Hospital Association; CK, creatine kinase. | |||||
| Three vessel disease | 180 (12.16%) | 139 (9.99%) | 160 (10.94%) | 139 (9.84%) | 131 (9.15%) |
| ACC/AHA worst lesion class type C* | 256 (17.59%) | 251 (18.42%) | 232 (16.28%) | 230 (16.65%) | 200 (14.36%) |
| ACC/AHA worst lesion class type B2* | 811 (55.74%) | 774 (56.79%) | 831 (58.32%) | 845 (61.19%) | 864 (62.02%) |
| ACC/AHA worst lesion class type B1* | 223 (15.33%) | 216 (15.85%) | 230 (16.14%) | 198 (14.34%) | 211 (15.15%) |
| ACC/AHA worst lesion class type A* | 165 (11.34%) | 122 (8.95%) | 132 (9.26%) | 108 (7.82%) | 118 (8.47%) |
| Lesion thrombus* | 196 (13.40%) | 241 (17.57%) | 231 (16.05%) | 278 (20.01%) | 346 (24.61%) |
| Major or minor bleeding* | 168 (11.40%) | 135 (9.73%) | 148 (10.21%) | 163 (11.59%) | 217 (15.24%) |
| Postprocedural CK-MB increase* | 267 (18.30%) | 276 (20.32%) | 301 (20.92%) | 284 (20.58%) | 376 (26.63%) |
| Postprocedural creatinine >1.5 mg/dl* | 85 (5.77%) | 84 (6.07%) | 89 (6.13%) | 102 (7.27%) | 104 (7.31) |